
The Qubit Report: October 14, 2026
IonQ priced a $2.0 billion equity offering while Qilimanjaro closed nearly €20 million in its Series A with Indra and Spanish SETT capital. The same cycle brought Quantum Computing Inc. its first pharma customer via INmune Bio’s Dirac-3S work on XPro, SEALSQ’s ML-KEM attack research plus new chips, and Anderon’s superconducting quantum PDK. The wrap-up has the figures, the countermeasures, and the source list.







